Literature DB >> 34966862

Reductions in the Frequency of Going Out Due to the COVID-19 Pandemic Negatively Affect Patients with Spinal Disorders.

Hidetomi Terai1, Masayoshi Iwamae1, Koji Tamai1, Shinji Takahashi1, Yusuke Hori1, Shoichiro Ohyama1, Akito Yabu1, Masatoshi Hoshino1, Hiroaki Nakamura1.   

Abstract

INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic has greatly changed the lifestyles of individuals due to the need to prevent disease spread. Globally, governments have enforced various policies, including travel bans, quarantine, home confinement, and lockdowns, as safety measures. Consequently, the frequency of individuals going out has decreased. This survey aimed to assess how decreasing the frequency of going out due to the COVID-19 pandemic impacts patients with spinal disorders.
METHODS: This multicenter cross-sectional questionnaire survey included patients who visited four private spine clinics for any symptoms. Participants completed questionnaires pre- and post-pandemic that assessed the following topics: frequency of leaving home, exercise habits, locomotive syndrome, and health-related quality of life (HRQOL). Patients were divided into decreased and non-decreased frequency of going out groups, according to observed changes in their frequencies of leaving home. Both groups were statistically compared using univariate and multivariate logistic regression analyses to identify factors associated with the frequency of going out.
RESULTS: Among 855 patients, 160 (18.7%; the decreased group) reported that they went out less frequently, and 695 (81.3%; the non-decreased group) reported that they left home equally frequently post- versus pre-pandemic. Multivariate analyses showed that exercise habits significantly decreased (adjusted odds ratio (aOR) = 2.67, p = 0.004), the incidence of locomotive syndrome significantly increased (aOR = 2.86, p = 0.012), and HRQOL significantly deteriorated (aOR = 4.14, p < 0.001) in the decreased group compared to the non-decreased group.
CONCLUSIONS: Restrictions regarding leaving home due to the COVID-19 pandemic significantly decreased exercise frequency, increased the occurrence of locomotive syndrome, and were associated with deterioration of HRQOL in patients with spine disorders. It may be beneficial for spine surgeons to encourage patients with spinal disorders to leave home at a frequency similar to what they did pre-pandemic while avoiding crowded areas, despite the presence of the COVID-19 pandemic.
Copyright © 2021 by The Japanese Society for Spine Surgery and Related Research.

Entities:  

Keywords:  COVID-19; exercise habit; frequency of going out; locomotive syndrome; pandemic; quality of life; spinal disorder; staying at home

Year:  2021        PMID: 34966862      PMCID: PMC8668221          DOI: 10.22603/ssrr.2021-0088

Source DB:  PubMed          Journal:  Spine Surg Relat Res        ISSN: 2432-261X


  32 in total

1.  Association between "loco-check" and EuroQol, a comprehensive instrument for assessing health-related quality of life: a study of the Japanese general population.

Authors:  Yoichi Iizuka; Haku Iizuka; Tokue Mieda; Tsuyoshi Tajika; Atsushi Yamamoto; Kenji Takagishi
Journal:  J Orthop Sci       Date:  2014-07-15       Impact factor: 1.601

2.  Evaluation of locomotive disability using loco-check: a cross-sectional study in the Japanese general population.

Authors:  Eiji Sasaki; Yasuyuki Ishibashi; Eiichi Tsuda; Atsushi Ono; Yuji Yamamoto; Ryo Inoue; Ippei Takahashi; Takashi Umeda; Shigeyuki Nakaji
Journal:  J Orthop Sci       Date:  2012-11-01       Impact factor: 1.601

3.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

4.  Quantitative assessment of locomotive syndrome by the loco-check questionnaire in older Japanese females.

Authors:  Sachiko Noge; Tatsuo Ohishi; Takuya Yoshida; Hiromichi Kumagai
Journal:  J Phys Ther Sci       Date:  2017-09-15

5.  The impact of physical activity on psychological health during Covid-19 pandemic in Italy.

Authors:  Grazia Maugeri; Paola Castrogiovanni; Giuseppe Battaglia; Roberto Pippi; Velia D'Agata; Antonio Palma; Michelino Di Rosa; Giuseppe Musumeci
Journal:  Heliyon       Date:  2020-06-24

6.  Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis.

Authors:  Nader Salari; Amin Hosseinian-Far; Rostam Jalali; Aliakbar Vaisi-Raygani; Shna Rasoulpoor; Masoud Mohammadi; Shabnam Rasoulpoor; Behnam Khaledi-Paveh
Journal:  Global Health       Date:  2020-07-06       Impact factor: 4.185

7.  Lifestyle behaviours during the COVID-19 - time to connect.

Authors:  V Balanzá-Martínez; B Atienza-Carbonell; F Kapczinski; R B De Boni
Journal:  Acta Psychiatr Scand       Date:  2020-05       Impact factor: 6.392

8.  Association between musculoskeletal function deterioration and locomotive syndrome in the general elderly population: a Japanese cohort survey randomly sampled from a basic resident registry.

Authors:  Ryosuke Tokida; Shota Ikegami; Jun Takahashi; Yoshikazu Ido; Ayaka Sato; Noriko Sakai; Hiroshi Horiuchi; Hiroyuki Kato
Journal:  BMC Musculoskelet Disord       Date:  2020-07-03       Impact factor: 2.362

9.  Locomotive Syndrome Stage 1 Predicts Significant Worsening of Future Motor Performance: The Prospective Yakumo Study.

Authors:  Kazuyoshi Kobayashi; Shiro Imagama; Kei Ando; Masaaki Machino; Satoshi Tanaka; Masayoshi Morozumi; Shunsuke Kanbara; Sadayuki Ito; Taro Inoue; Naoki Ishiguro; Yukiharu Hasegawa
Journal:  Biomed Res Int       Date:  2019-10-03       Impact factor: 3.411

10.  The Relationship between Cognitive Function, Lifestyle Behaviours and Perception of Stress during the COVID-19 Induced Confinement: Insights from Correlational and Mediation Analyses.

Authors:  Hela Znazen; Maamer Slimani; Nicola Luigi Bragazzi; David Tod
Journal:  Int J Environ Res Public Health       Date:  2021-03-19       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.